Teddi Mellencamp reveals graphic picture of her surgery scar in honor of World Cancer Day - The Real Housewives of Beverly ...

The researchers found that imlunestrant prolonged progression-free survival (PFS) when compared to standard care in patients with ESR1 mutations, but there was no PFS benefit observed in the overall ...

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

Lawyers claim Johnson & Johnson knew that the product contained cancer causing asbestos, but failed to warn customers and ...

A MUM has shared a shocking photo of a giant lump protruding from her breast, which doctors repeatedly dismissed a benign. But after months of being told there was nothing to worry about, Tirzah ...

Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...

Breast cancer cases and its economic impact are projected to grow substantially in India, with an annual increase rate of 5.6%. The economic burden of breast cancer to increase to $13.96 billion by ...

Medicare covers inpatient and outpatient care for skin cancer. People with Original Medicare parts A and B or Medicare Advantage plans can expect extensive coverage, but they will likely have out ...

The stage of melanoma skin cancer tells you how thick it is and how far it has spread. Doctors use different systems to stage melanoma. These include the TNM system and number staging system. The ...

I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo editing software, and how operating systems change over time. I was ...

Cancer rates are increasing among women under 50, and women between 50 to 64 are now diagnosed more often than men. Breast cancer is the most common and lethal cancer in women globally. Early ...

With an FDA approval for HER2-positive breast cancer already in the bag, Daiichi Sankyo and AstraZeneca’s Enhertu now looks like it may be able to add lung, stomach and colorectal cancer to its ...